TAT and disease arising from reactivation of latent virus: While the use of early Tat inhibitors was not successful in suppressing active infection and had potential non-specific toxicity, the effectiveness of newer Tat inhibitors in driving latent infection into a silenced state remains to be clinically evaluated [18].